- Home
- AUTL vs MLAB Comparison
AUTL vs MLAB Comparison
Compare AUTL & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- MLAB
- Stock Information
- Founded
- AUTL 2014
- MLAB 1982
- Country
- AUTL United Kingdom
- MLAB United States
- Employees
- AUTL N/A
- MLAB N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- MLAB Industrial Machinery/Components
- Sector
- AUTL Health Care
- MLAB Industrials
- Exchange
- AUTL Nasdaq
- MLAB Nasdaq
- Market Cap
- AUTL 590.8M
- MLAB 692.9M
- IPO Year
- AUTL 2018
- MLAB N/A
- Fundamental
- Price
- AUTL $2.19
- MLAB $146.64
- Analyst Decision
- AUTL Strong Buy
- MLAB Hold
- Analyst Count
- AUTL 3
- MLAB 2
- Target Price
- AUTL $10.20
- MLAB $140.00
- AVG Volume (30 Days)
- AUTL 1.4M
- MLAB 38.7K
- Earning Date
- AUTL 03-13-2025
- MLAB 02-03-2025
- Dividend Yield
- AUTL N/A
- MLAB 0.44%
- EPS Growth
- AUTL N/A
- MLAB N/A
- EPS
- AUTL N/A
- MLAB N/A
- Revenue
- AUTL $10,091,000.00
- MLAB $228,380,000.00
- Revenue This Year
- AUTL $851.83
- MLAB $11.39
- Revenue Next Year
- AUTL $264.18
- MLAB $5.62
- P/E Ratio
- AUTL N/A
- MLAB N/A
- Revenue Growth
- AUTL 82.71
- MLAB 6.88
- 52 Week Low
- AUTL $2.07
- MLAB $83.68
- 52 Week High
- AUTL $7.37
- MLAB $147.34
- Technical
- Relative Strength Index (RSI)
- AUTL 37.25
- MLAB 65.08
- Support Level
- AUTL $2.18
- MLAB $131.90
- Resistance Level
- AUTL $2.38
- MLAB $147.34
- Average True Range (ATR)
- AUTL 0.16
- MLAB 5.60
- MACD
- AUTL 0.01
- MLAB 0.19
- Stochastic Oscillator
- AUTL 3.17
- MLAB 96.77
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.